Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Updates on 18F-FDG-PET/CT as a clinical tool for tuberculosis evaluation and therapeutic monitoring.

Yu WY, Lu PX, Assadi M, Huang XL, Skrahin A, Rosenthal A, Gabrielian A, Tartakovsky M, Wáng YXJ.

Quant Imaging Med Surg. 2019 Jun;9(6):1132-1146. doi: 10.21037/qims.2019.05.24.

2.

Differences in response to antiretroviral therapy in HIV-positive patients being treated for tuberculosis in Eastern Europe, Western Europe and Latin America.

Caro-Vega Y, Schultze A, W Efsen AM, Post FA, Panteleev A, Skrahin A, Miro JM, Girardi E, Podlekareva DN, Lundgren JD, Sierra-Madero J, Toibaro J, Andrade-Villanueva J, Tetradov S, Fehr J, Caylà J, Losso MH, Miller RF, Mocroft A, Kirk O, Crabtree-Ramírez B.

BMC Infect Dis. 2018 Apr 23;18(1):191. doi: 10.1186/s12879-018-3077-x.

3.

Radiological signs associated with pulmonary multi-drug resistant tuberculosis: an analysis of published evidences.

Wáng YXJ, Chung MJ, Skrahin A, Rosenthal A, Gabrielian A, Tartakovsky M.

Quant Imaging Med Surg. 2018 Mar;8(2):161-173. doi: 10.21037/qims.2018.03.06.

4.

Management of MDR-TB in HIV co-infected patients in Eastern Europe: Results from the TB:HIV study.

Efsen AMW, Schultze A, Miller RF, Panteleev A, Skrahin A, Podlekareva DN, Miro JM, Girardi E, Furrer H, Losso MH, Toibaro J, Caylà JA, Mocroft A, Lundgren JD, Post FA, Kirk O; TB: HIV study in EuroCoord.

J Infect. 2018 Jan;76(1):44-54. doi: 10.1016/j.jinf.2017.10.007. Epub 2017 Oct 20.

5.

The TB Portals: an Open-Access, Web-Based Platform for Global Drug-Resistant-Tuberculosis Data Sharing and Analysis.

Rosenthal A, Gabrielian A, Engle E, Hurt DE, Alexandru S, Crudu V, Sergueev E, Kirichenko V, Lapitskii V, Snezhko E, Kovalev V, Astrovko A, Skrahina A, Taaffe J, Harris M, Long A, Wollenberg K, Akhundova I, Ismayilova S, Skrahin A, Mammadbayov E, Gadirova H, Abuzarov R, Seyfaddinova M, Avaliani Z, Strambu I, Zaharia D, Muntean A, Ghita E, Bogdan M, Mindru R, Spinu V, Sora A, Ene C, Vashakidze S, Shubladze N, Nanava U, Tuzikov A, Tartakovsky M.

J Clin Microbiol. 2017 Nov;55(11):3267-3282. doi: 10.1128/JCM.01013-17. Epub 2017 Sep 13.

6.

Effectiveness of a novel cellular therapy to treat multidrug-resistant tuberculosis.

Skrahin A, Jenkins HE, Hurevich H, Solodovnikova V, Isaikina Y, Klimuk D, Rohava Z, Skrahina A.

Int J Mycobacteriol. 2016 Dec;5 Suppl 1:S23. doi: 10.1016/j.ijmyco.2016.11.018. Epub 2016 Nov 29.

7.

Whole-Genome Sequencing of Mycobacterium tuberculosis Provides Insight into the Evolution and Genetic Composition of Drug-Resistant Tuberculosis in Belarus.

Wollenberg KR, Desjardins CA, Zalutskaya A, Slodovnikova V, Oler AJ, Quiñones M, Abeel T, Chapman SB, Tartakovsky M, Gabrielian A, Hoffner S, Skrahin A, Birren BW, Rosenthal A, Skrahina A, Earl AM.

J Clin Microbiol. 2017 Feb;55(2):457-469. doi: 10.1128/JCM.02116-16. Epub 2016 Nov 30.

8.

7th Union Europe Conference on Lung Health, 22-24 June 2016, Bratislava (Slovakia): a delegate report.

Skrahin A.

Quant Imaging Med Surg. 2016 Aug;6(4):338-341. No abstract available.

9.

Effectiveness of a novel cellular therapy to treat multidrug-resistant tuberculosis.

Skrahin A, Jenkins HE, Hurevich H, Solodovnikova V, Isaikina Y, Klimuk D, Rohava Z, Skrahina A.

J Clin Tuberc Other Mycobact Dis. 2016 Aug;4:21-27.

10.

Major Challenges in Clinical Management of TB/HIV Coinfected Patients in Eastern Europe Compared with Western Europe and Latin America.

Efsen AM, Schultze A, Post FA, Panteleev A, Furrer H, Miller RF, Losso MH, Toibaro J, Skrahin A, Miro JM, Caylà JA, Girardi E, Bruyand M, Obel N, Podlekareva DN, Lundgren JD, Mocroft A, Kirk O; TB:HIV study group in EuroCoord.

PLoS One. 2015 Dec 30;10(12):e0145380. doi: 10.1371/journal.pone.0145380. eCollection 2015.

11.

Major challenges in clinical management of TB/HIV co-infected patients in Eastern Europe compared with Western Europe and Latin America.

Efsen AM, Schultze A, Post F, Panteleev A, Furrer H, Miller R, Skrahin A, Losso MH, Toibaro J, Girardi E, Miro J, Bruyand M, Obel N, Caylá J, Podlekareva D, Lundgren J, Mocroft A, Kirk O.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19505. doi: 10.7448/IAS.17.4.19505. eCollection 2014.

12.

Autologous mesenchymal stromal cell infusion as adjunct treatment in patients with multidrug and extensively drug-resistant tuberculosis: an open-label phase 1 safety trial.

Skrahin A, Ahmed RK, Ferrara G, Rane L, Poiret T, Isaikina Y, Skrahina A, Zumla A, Maeurer MJ.

Lancet Respir Med. 2014 Feb;2(2):108-22. doi: 10.1016/S2213-2600(13)70234-0. Epub 2014 Jan 9.

PMID:
24503266

Supplemental Content

Loading ...
Support Center